Justices Won't Review FTC's Impax Ruling
By Matthew Perlman ( December 13, 2021, 6:36 PM EST) -- The U.S. Supreme Court has declined to take up Impax Laboratories' request to undo a Fifth Circuit decision upholding the Federal Trade Commission's finding that the drugmaker illegally delayed a generic version of opioid pain medication Opana ER....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.